
According to data from Benzinga Pro, during Q4, Zosano Pharma's (NASDAQ:ZSAN) reported sales totaled $87.00 thousand. Despite a 19.58% increase in earnings, the company posted a loss of $6.97 million. Zosano Pharma collected $252.00 thousand in revenue during Q3, but reported earnings showed a $8.67 million loss.